Open-Label, Single Arm Phase II Trial Investigating the Efficacy, Safety and Quality of Life of Neoadjuvant Chemotherapy with Liposomal Irinotecan Combined with Oxaliplatin and 5-Fluorouracil/Folinic Acid Followed by Curative Surgical Resection in Patients with Hepatic Oligometastatic Adenocarcinoma of the Pancreas (HOLIPANC)

liposomales Irinotecan (Onivyde®), Oxaliplatin und 5-FU/Folinsäure

Status: In Rekrutierung

Klinische Settings

Beteiligte

Identifier

Links

Kontakt